Table 3.
LPS 1 μg/mL + melittin 0.5 μM |
||||||
---|---|---|---|---|---|---|
Control | Vehicle | PINE 6.25 μg/mL | PINE 12.5 μg/mL | PINE 25 μg/mL | Dexa 10 μg/mL | |
IL-1β | 2.97 ± 2.36 | 18.94 ± 1.77# | 20.33 ± 0.59 | 19.50 ± 1.77 | 10.61 ± 0.98* | 5.33 ± 1.37* |
PGE2 | 11.79 ± 4.30 | 904.73 ± 60.59# | 778.82 ± 22.37 | 321.50 ± 30.73** | 160.16 ± 16.84** | 148.38 ± 8.52** |
Cells were pre-treated with PINE (6.25, 12.5 or 25 μg/mL) for 1 h and then treated with LPS (1 μg/mL) and melittin (0.5 μM) for 12 h. The ELISA was performed to measure the levels of IL-1β and PGE2. Dexamethasone (Dexa) (10 μg/mL) was used as the reference compound. The absorbance was measured at 450 nm, and each value represents the mean ± SD (n = 3). Significantly different from the control (#p < 0.05). Significantly different from the stimulation group (*p < 0.05 and **p < 0.01).